Medifocus, Inc. Announces Food And Drug Administration FDA Update For Its Pivotal Phase III Clinical Trial For Treatment Of Breast Cancer: Files Response To Two Remaining Questions

Medifocus, Inc. is pleased to announce that it has filed on January 22, 2010, its response to two (2) remaining questions with the FDA in the United States of America (USA) to obtain clearance to initiate a pivotal phase III clinical trial using the Company’s Microfocus APA 1000 System for the treatment of breast cancer in the USA and worldwide. Source: General Cancer News Articles Provided by Cancer Compass

Neoprobe Announces Successful Meeting On Lymphoseek Phase 3 Results
Guided Therapeutics' LightTouch Cervical Scan Detected Disease Up To Two Years Earlier Than Pap, HPV And Biopsy In FDA Pivotal Clinical Trial
Denosumab Demonstrated Superiority Over Zometa In Pivotal Phase 3 Head-To-Head Trial In Prostate Cancer Patients With Bone Metastases
Initiation Of Phase I Combination Clinical Trial Of Brentuximab Vedotin SGN-35 For Front-Line Hodgkin Lymphoma
ArQule Announces Initiation of Clinical Programs with ARQ 197 in Germ Cell Tumors and Colorectal Cancer
Committee Recommends Continuation Of Phase III Study Of StemEx For Leukemia And Lymphoma
Telormedix' TMX-101 Commences Clinical Trial For Bladder Cancer
GTx Announces Top Line Results Of Phase III Clinical Trial Evaluating Toremifene 20 mg For The Prevention Of Prostate Cancer In Men With High Grade PIN
Celldex Therapeutics Announces Initiation Of Randomized Phase 2 Clinical Trial Of CDX-1307 In Front Line Bladder Cancer
Kinex Pharmaceuticals Initiates A Phase 2 Clinical Trial Of KX2-391 In Patients With Prostate Cancer
Late-Stage Ovarian Cancer Shows Promise In Two-Drug Phase I Trial
ZIOPHARM Commences Oral Indibulin Phase I/II Trial In Breast Cancer
Synta Announces Positive Results In Phase 2 NSCLC Trial For STA-9090 Support Advancing Trial To Second Stage
OSI Pharmaceuticals Announces That RADIANT, An International Phase III Tarceva Adjuvant Trial In Non-Small Cell Lung Cancer, Completes Enrollment
Research raises questions about breast cancer treatment

Tags: Administration, Announces, Breast, Cancer, Clinical, Drug, Files, Food, Inc., Medifocus, Phase, Pivotal, Questions, Remaining, Response, Treatment, Trial, Update
Posted in Cancer on | There are currently No Comments

Cancer Cure Books

Sponsored Links

Medifocus, Inc. Announces Food And Drug Administration FDA Update For Its Pivotal Phase III Clinical Trial For Treatment Of Breast Cancer: Files Response To Two Remaining Questions

Related Posts:

Leave a Reply